The SMARTFLOW Trial Program will assess the role of quality control in coronary artery bypass grafting.
Absolute Event Rate: 0% vs 0%
2026-11-29
Gaudino et al. (Thu,) reported a other. The SMARTFLOW Trial Program will assess the role of quality control in coronary artery bypass grafting.